From experienceproject.com
()
Types of Arthritis
Arthritis affects joints and can impede movement, cause swelling, and inflict pain
I was just diagnosed yesterday after both my wrists were burning up below the thumbs at the tendons. I have had terrible joint pain for 12 years, mostly in my lower back, toes and thumbs. I've had terrible gout before. I have never had this type of t...
More perspectives...
if body allergic to milk (or any other food), stomach the first place where immune system responds
More perspectives...
From del.icio.us
()
A Swedish study has concluded that rheumatoid arthritis patients did not experience an increased cancer risk in the first 6 years of treatment with TNF blockers. Researchers from Karolinska University Hospital in Stockholm assessed short-term and medium-term cancer risk in rheumatoid arthritis patients using Remicade, Humira, and Enbrel.
According to the report published in the November 2009 issue of Arthritis & Rheumatism, the study was one...
From z.about.com
()
- Glucosamine For Osteoarthritis Pain. (tipsanswers.com)
NEW YORK (Reuters Health) - Early use of disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis is cost-effective, according to a report in the Annals of Internal Medicine for November 3. Whether the same holds true for biologic agents, however, will require further study.
More perspectives...
From rehabpub.com
()
Background:
Long-term control or remission of rheumatoid arthritis (RA) may be possible with very early treatment. However, no optimal first therapeutic strategy has been determined.
Objective:
To assess the potential cost-effectiveness of major therapeutic strategies for very early RA.
Design:
Decision analytic model with probabilistic sensitivity analyses.
Data Sources:
Published data, the National Data Bank for Rheumatic Diseases, and...
From annals.org
()
- FLU.GOV: People with Rheumatoid Arthritis Are at High Risk for Serious Flu... (media-newswire.com)
- Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roche's... (rss.prnewswire.com)
